Cost‐effectiveness of a proposed feasibility study on the detection of early lung carcinoma in Germany

• Published in: Cancer Vol. 89; no. S11; pp. 2494 - 2496
• Main Author: Nakhosteen, John A.
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.12.2000; Wiley-Liss
• Subjects: Aged; Biological and medical sciences; Bronchoscopy - economics; Bronchoscopy - methods; Carcinoma - diagnosis; Carcinoma - economics; Carcinoma - epidemiology; Carcinoma - prevention & control; Cost-Benefit Analysis; Feasibility Studies; Female; Fluorescence; Germany - epidemiology; Humans; Incidence; Lung Neoplasms - diagnosis; Lung Neoplasms - economics; Lung Neoplasms - epidemiology; Lung Neoplasms - prevention & control; Male; Mass Chest X-Ray; Mass Screening - economics; Mass Screening - methods; Medical sciences; Middle Aged; Neoplasm Staging; Pneumology; Prevalence; Randomized Controlled Trials as Topic - economics; Risk Factors; Sputum - cytology; Tumors of the respiratory system and mediastinum; Europe; Germany; Bronchoscopy; Human; Lung disease; Carcinoma; Respiratory disease; Cytology; Fluorescence; Malignant tumor; Medical screening; Bronchopulmonary; Pathology; Cytometry; Health economy; Sputum; Automatic system; Bronchus disease; Cytopathology; Early; Endoscopy; Diagnosis; Public health; Cost efficiency analysis
• ISSN: 0008-543X; 1097-0142
• DOI: 10.1002/1097-0142(20001201)89:11+<2494::AID-CNCR30>3.0.CO;2-H

A randomized, controlled study combining new technologies with more conventional methods for the detection of early lung carcinoma is planned for 6000 high risk patients. A cost‐benefit analysis has shown a projected doubling of the 5‐year survival rate with an approximate 20% increase in total (screening and treatment) costs in the screened group compared with the control group.